Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03413995
Title	Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene Mutations (TRIUMPH)
Acronym	TRIUMPH
Recruitment	Completed
Gender	male
Phase	Phase II
Variant Requirements	Yes
Sponsors	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications	prostate adenocarcinoma
Therapies	Rucaparib
Age Groups:	adult \| senior
Covered Countries	USA